retatrutide patent eli lilly Lilly's triple-acting obesity drug hits goal in Phase 3 trial retatrutide patent The FDA has
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28

























